Clinical TrialsSearch results
Number of results: 596
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Other
- Randomiszd phase III trial of adjuvant chemotherapy with gemcitabine vs. S-1 in patients with resected pancreatic cancer
- Resected pancreatic cancer
- Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)
- 2007-04-01
Other
- clinical trial of CHP-HER2 cancer vaccine with immuno-adjuvant, OK-432, for advanced breast cancer
- Resected locally-advanced breast cancer
- Mie University, University of Ocupational and Environmental Health, Nagasaki University, National Hospital Organization Saga National Hospital, Hamamatsu Medical Center
- 2008-08-02
Completed
- Randomized phase II trial of chemoradiotherapy with S-1 versus gemcitabine and S-1 combination therapy as neoadjuvant treatment in patients with resectable pancreatic cancer
- resectable pancreatic cancer
- Uesaka Katsuhiko
- 2019-02-22
Completed
- The efficacy of elobixibat as bowel cleansing agent for bowel preparation before colonoscopy
- require colonoscopy
- Yamaguchi Daisuke
- 2019-01-16
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Completed
- A study on the relationship between subjective fatigue level before and after work and oxidative stress in forestry workers
- Relationship between workload and oxidative stress and antioxidant capacity in forestry workers.
- Odagiri Keiichi
- 2023-02-09
Other
- Study of PF-06863135 Monotherapy and PF-06863135 + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- relapsed/refractory multiple myeloma
- Kawai Norisuke
- 2021-11-02